EUVIMEDEUVIMED entdecken
Open Access

Impact of early immunosuppression on pediatric liver transplant outcomes within 1 year

Vikram K Raghu iD, Xingyu Zhang, James E Squires, Elizabeth Eisenberg, Amy G Feldman, Jennifer Halma, Anna L Peters, Regino P Gonzalez-Peralta, Vicky L Ng, Simon P Horslen, Steven J Lobritto, John Bucuvalas und 2 weitere

Journal of Pediatric Gastroenterology and Nutrition · 2024

DOI: 10.1002/jpn3.12112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2024. Verfasst von Vikram K Raghu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Liver Transplantation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The Starzl Network for Excellence in Pediatric Transplantation identified optimizing immunosuppression (IS) as a priority practice improvement area for patients, families, and providers. We aimed to evaluate associations between clinical characteristics, early IS, and outcomes.

Methods

We analyzed pediatric liver transplant (LT) data from 2013 to 2018 in the United Network for Organ Sharing (UNOS) and the Society of Pediatric Liver Transplantation (SPLIT) registries.

Results

We included 2542 LT recipients in UNOS and 1590 in SPLIT. IS choice varied between centers with steroid induction and mycophenolate mofetil (MMF) use each ranging from 0% to 100% across centers. Clinical characteristics associated with early IS choice were inconsistent between the two data sets. T‐cell depleting antibody use was associated with improved 1‐year graft (hazard ratio [HR] 0.50, 95% confidence interval [CI] 0.34−0.76) and patient (HR 0.40, 95% CI 0.20−0.79) survival in UNOS but decreased 1‐year patient survival (HR 4.12, 95% CI 1.31−12.93) and increased acute rejection (HR 1.58, 95% CI 1.07−2.34) in SPLIT. Non‐T‐cell depleting antibody use was not associated with differential risk of survival nor rejection. MMF use was associated with improved 1‐year graft survival (HR 0.73, 95% CI 0.54−0.99) in UNOS only.

Conclusions

Variation exists in center choice of early IS regimen. UNOS and SPLIT data provide conflicting associations between IS and outcomes in multivariable analysis. These results highlight the need for future multicenter collaborative work to identify evidence‐based IS best practices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationLiver TransplantationChildHumansGraft RejectionGraft SurvivalImmunosuppression TherapyImmunosuppressive AgentsMycophenolic Acid

Stichwörter der Autor:innen

anti-thymocyte globulinbasiliximabcorticosteroidsmycophenolate mofetilsurvival

Substanzen

Immunosuppressive AgentsMycophenolic Acid

Autor:innen und Institutionen

  • Department of Pediatrics, University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Thomas E. Starzl Transplantation Institute, Pittsburgh, Pennsylvania, USA.
  • Patient and Family Voice, Starzl Network for Excellence in Pediatric Transplantation, Pittsburgh, Pennsylvania, USA.
  • Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
  • Division of Gastroenterology, Hepatology, and Nutrition, Stanford Medicine Children's Health, Palo Alto, California, USA.
  • Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.

ORCID-Profile: Vikram K Raghu

Förderung

  • NCATS NIH HHS

Zitieren

APA

Raghu, V. K., Zhang, X., Squires, J. E., Eisenberg, E., Feldman, A. G., Halma, J., Peters, A. L., Gonzalez-Peralta, R. P., Ng, V. L., Horslen, S. P., Lobritto, S. J., Bucuvalas, J., Mazariegos, G. V., & Perito, E. R. (2024). Impact of early immunosuppression on pediatric liver transplant outcomes within 1 year. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12112

Vancouver

Raghu VK, Zhang X, Squires JE, Eisenberg E, Feldman AG, Halma J, et al. Impact of early immunosuppression on pediatric liver transplant outcomes within 1 year. Journal of Pediatric Gastroenterology and Nutrition. 2024. doi:10.1002/jpn3.12112

BibTeX
@article{Raghu2024,
  author = {Raghu, Vikram K and Zhang, Xingyu and Squires, James E and Eisenberg, Elizabeth and Feldman, Amy G and Halma, Jennifer and Peters, Anna L and Gonzalez-Peralta, Regino P and Ng, Vicky L and Horslen, Simon P and Lobritto, Steven J and Bucuvalas, John and Mazariegos, George V and Perito, Emily R},
  title = {Impact of early immunosuppression on pediatric liver transplant outcomes within 1 year},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2024},
  doi = {10.1002/jpn3.12112}
}
Kostenlos starten →